Similar articles

• [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].

  Baluda VP, Sushkevich GN, Lukoianova TI. Baluda VP, et al. Patol Fiziol Eksp Ter. 1980;(4):80-5. Patol Fiziol Eksp Ter. 1980. PMID: 6251418 Review. Russian. No abstract available.
• Analogues of arachidonic acid used to evaluate structural determinants of prostaglandin receptor and enzyme specificities.

  LeDuc LE, Wyche AA, Sprecher H, Sankarappe SK, Needleman P. LeDuc LE, et al. Mol Pharmacol. 1981 Mar;19(2):242-7. Mol Pharmacol. 1981. PMID: 6262618 No abstract available.
• Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.

  Smith JB, Araki H, Lefer AM. Smith JB, et al. Circulation. 1980 Dec;62(6 Pt 2):V19-25. Circulation. 1980. PMID: 7002350 Review.
• Prostacyclin in physiology and pathophysiology.

  Vane JR, Bunting S, Moncada S. Vane JR, et al. Int Rev Exp Pathol. 1982;23:161-207. Int Rev Exp Pathol. 1982. PMID: 6806207 Review. No abstract available.
• Prostaglandins and thromboxanes: biochemical and physiological considerations.

  Samuelsson B, Folco G, Granström E, Kindahl H, Malmsten C. Samuelsson B, et al. Adv Prostaglandin Thromboxane Res. 1978;4:1-25. Adv Prostaglandin Thromboxane Res. 1978. PMID: 347910 Review. No abstract available.